M. E. Gedik Et Al. , "Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer," Cancer research , vol.84, no.9, pp.1475-1490, 2024
Gedik, M. E. Et Al. 2024. Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer. Cancer research , vol.84, no.9 , 1475-1490.
Gedik, M. E., Saatci, O., Oberholtzer, N., ÜNER, M., Akbulut Caliskan, O., Cetin, M., ... Aras, M.(2024). Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer. Cancer research , vol.84, no.9, 1475-1490.
Gedik, Mustafa Et Al. "Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer," Cancer research , vol.84, no.9, 1475-1490, 2024
Gedik, Mustafa E. Et Al. "Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer." Cancer research , vol.84, no.9, pp.1475-1490, 2024
Gedik, M. E. Et Al. (2024) . "Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer." Cancer research , vol.84, no.9, pp.1475-1490.
@article{article, author={Mustafa Emre Gedik Et Al. }, title={Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer}, journal={Cancer research}, year=2024, pages={1475-1490} }